Ahead of the 10-year anniversary of Tagrisso’s initial FDA approval this fall, AstraZeneca has debuted the first direct-to-consumer commercial for the lung cancer med. | Ahead of the 10-year ...

AstraZeneca PLC Sponsored ADR (AZN) is currently at $72.92, up $2.44 or 3.46% --Would be highest close since June 16, 2025, when it closed at $73.55 --On pace for largest percent increase since April ...

AstraZeneca (Cambridge, U.K.) announced $50 billion of investment in the United States by 2030, building on America’s global leadership in medicines ...